Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Deb

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative GroupA Donfrancesco, B De Bernardi, M Carli, et al.
Progress in Clinical and Biological Research|January 1, 1991
High-dose carboplatin with etoposide (JET regimen) in children with advanced neuroblastomaM A Castello, A Donfrancesco, A Clerico, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|June 5, 2004
Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of ageA Donfrancesco, A Jenkner, A Castellano, et al.
International Journal of Oral and Maxillofacial Surgery|July 7, 2015
A split-mouth, randomized, triple-blind, placebo-controlled study to analyze the pre-emptive effect of etoricoxib 120 mg on inflammatory events following removal of unerupted mandibular third molarsF W G Costa, E C S Soares, D F S Esses, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative GroupA Donfrancesco, B De Bernardi, M Carli, et al.
Progress in Clinical and Biological Research|January 1, 1991
High-dose carboplatin with etoposide (JET regimen) in children with advanced neuroblastomaM A Castello, A Donfrancesco, A Clerico, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|June 5, 2004
Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of ageA Donfrancesco, A Jenkner, A Castellano, et al.
International Journal of Oral and Maxillofacial Surgery|July 7, 2015
A split-mouth, randomized, triple-blind, placebo-controlled study to analyze the pre-emptive effect of etoricoxib 120 mg on inflammatory events following removal of unerupted mandibular third molarsF W G Costa, E C S Soares, D F S Esses, et al.
Pageof 3